Deborah Stewart - 30 Dec 2025 Form 4 Insider Report for Aveanna Healthcare Holdings, Inc. (AVAH)

Role
SVP, Chief Accounting Officer
Signature
/s/ Jonathan Beckler, Attorney-in-Fact
Issuer symbol
AVAH
Transactions as of
30 Dec 2025
Net transactions value
-$281,126
Form type
4
Filing time
02 Jan 2026, 20:31:54 UTC
Previous filing
11 Jun 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Stewart Deborah SVP, Chief Accounting Officer C/O AVEANNA HEALTHCARE HOLDINGS INC., 400 INTERSTATE NORTH PARKWAY SE, ATLANTA /s/ Jonathan Beckler, Attorney-in-Fact 02 Jan 2026 0001983702

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVAH Common Stock, par value $0.01 per share Sale $95,078 -11,379 -4% $8.36 274,913 30 Dec 2025 Direct F1, F2, F3
transaction AVAH Common Stock, par value $0.01 per share Sale $92,204 -11,275 -4.1% $8.18 263,638 31 Dec 2025 Direct F1, F4
transaction AVAH Common Stock, par value $0.01 per share Sale $93,844 -11,962 -4.5% $7.85 251,676 02 Jan 2026 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents shares of common stock automatically sold to satisfy the reporting person's tax obligation in respect of the shares issued upon vesting of equity awards, as previously reported.
F2 The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $8.255 to $8.45. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Includes 896 shares acquired under the Registrant's Employee Stock Purchase Plan (the "ESPP") in July 2025.
F4 The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $8.115 to $8.31. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F5 The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.70 to $8.19. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.